“…Since its first discovery by Toole’s group in 1992, thrombin-binding aptamer (TBA) has been widely studied in therapeutic and diagnostic applications because of its high affinity and good specificity. − As aptamers are oligonucleotides screened from a random sequence library via systematic evolution of ligands by exponential enrichment (SELEX) and can be chemically synthesized in vitro, they offer the benefits of low cost, high thermal stability, long shelf life, and minimal interbatch production variability as molecular recognition receptors. − During the past few decades, a variety of aptamer-based fluorescent, colorimetric, electrochemiluminescent (ECL), , surface-enhanced Raman scattering (SERS), , chromatographic, nanopore, photoelectrochemical (PEC), , and electrochemical − methods have been put forward for thrombin detection. Relative to other methods, electrochemical aptasensors have drawn much more attention in thrombin detection, because of their high detection sensitivity, low matrix interference, high selectivity, and simple instrument. , On the basis of the significant change in redox current caused by the target-induced conformational change, for example, Plaxco et al illustrated a method for the electrochemical aptasensing of thrombin, using the methylene blue (MB)-tagged TBA as the recognition receptor.…”